Related Experiment Video
Updated: Jan 29, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer
Shimiao Zhu1, Hao Tian1, Xiaodan Niu2
1Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, 300211, Tianjin, China.
Abstract:
Castration-resistant prostate cancer (CRPC) with neuroendocrine differentiation (NED) is a lethal disease for which effective therapies are urgently needed. The mechanism underlying development of CRPC with NED, however, remains largely uncharacterized. In this study, we explored and characterized the functional role of neurotensin (NTS) in cell line and animal models of CRPC with NED. NTS was acutely induced by androgen deprivation in animal models of prostate cancer (PCa) and activated downstream signaling leading to NED through activation of neurotensin receptor 1 (NTSR1) and neurotensin receptor 3 (NTSR3), but not neurotensin receptor 2 (NTSR2). Our findings also revealed the existence of a CK8+/CK14+ subpopulation in the LNCaP cell line that expresses high levels of both NTSR1 and NTSR3, and displays an enhanced susceptibility to develop neuroendocrine-like phenotypes upon treatment with NTS. More importantly, NTSR1 pathway inhibition prevented the development of NED and castration resistance in vivo. We propose a novel role of NTS in the development of CRPC with NED, and a possible strategy to prevent the onset of NED by targeting the NTS signaling pathway.
Insights
Neurotensin (NTS) drives castration-resistant prostate cancer (CRPC) with neuroendocrine differentiation (NED) by activating specific receptors. Targeting the NTS signaling pathway may prevent CRPC with NED development.
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Castration-resistant prostate cancer (CRPC) with neuroendocrine differentiation (NED) presents a significant therapeutic challenge due to poorly understood mechanisms.
- Effective treatments for CRPC with NED are urgently needed.
Purpose of the Study:
- To investigate the role of neurotensin (NTS) in the development of CRPC with NED.
- To characterize the signaling pathways involved in NTS-mediated neuroendocrine differentiation.
Main Methods:
- Utilized cell line (LNCaP) and animal models of prostate cancer (PCa) and CRPC with NED.
- Examined NTS induction by androgen deprivation.
- Assessed the role of neurotensin receptors (NTSR1, NTSR3) in NED development.
- Investigated the effect of NTSR1 pathway inhibition on CRPC with NED progression in vivo.
Main Results:
- Neurotensin (NTS) is acutely induced by androgen deprivation in prostate cancer models.
- NTS activates neurotensin receptor 1 (NTSR1) and neurotensin receptor 3 (NTSR3) to promote NED.
- A specific subpopulation of LNCaP cells (CK8+/CK14+) showed increased susceptibility to NTS-induced NED.
- Inhibition of the NTSR1 pathway effectively prevented NED and castration resistance in vivo.
Conclusions:
- Neurotensin (NTS) plays a critical role in the development of castration-resistant prostate cancer with neuroendocrine differentiation.
- Targeting the NTS signaling pathway, particularly NTSR1, offers a potential therapeutic strategy to prevent CRPC with NED.
Related Concept Videos
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Forced Transdifferentiation
Artificial...
Internal Receptors
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
G-protein Coupled Receptors

